Comments on NASDAQ Rulemaking

Self-Regulatory Organizations; The Nasdaq Stock Market LLC; Notice of Filing of Proposed Rule Change to Adopt a New Continued Listing Requirement

Comments have been received from individuals and entities using a variety of Letter Types:

Comment
A: 255
B: 7
C: 9

Filter comments

Date Received
Date Letter Type Commenter Name
Public Comment Andrew Simpson, Chief Executive Officer, HeartSciences, Inc.
Public Comment Benjamin L. Schiffrin, Director of Securities Policy, Better Markets, Inc.
Public Comment David Danovitch, Angela Gomes, Brendan O'Brien, and Phillip Carnevale, Sullivan & Worcester LLP
Public Comment James Toes, President & CEO, and Skarbek, Chairman, Security Traders Association Kevin
Public Comment Kevin Hadden
Public Comment Lucosky Brookman LLP, Law Firm
Public Comment Marc Indeglia, The Small Public Company Coalition
Public Comment Parker Blawusch
Public Comment Sullivan & Worcester LLP
Public Comment Blank Rome LLP
Public Comment Cary Claiborne, Chief Executive Officer, Adial Pharmaceuticals, Inc.
Public Comment Tigran Armenovich Hakobyan, Medical Device Engineer
Public Comment Jonathan Shechter
Public Comment Harish
Public Comment James Foster, Chief Executive Officer, Virax Biolabs Group Limited (NASDAQ: VRAX)
Public Comment Anonymous
Public Comment Anonymous
Public Comment Jennifer Dang
Public Comment Farooq Chaudhry
Public Comment Ben Ritter
Public Comment Braden
Public Comment Nick B.
Public Comment Finn Owsley, Citizen & Investor
Public Comment Siddarth Sampangi
Public Comment Isaac David Tyng Mather, Data Engineer
Public Comment Martin Elmes
Public Comment Anonymous
Public Comment H Scott Stadler
Public Comment David Carroll
Public Comment Benjamin Perley

Last Reviewed or Updated: Feb. 6, 2026

File Number
SR-NASDAQ-2026-004
Release Number
34-104688
Related Materials
How to submit comments